MEDICINOVA, INC. Operating Cash Flow
MEDICINOVA, INC. (MNOV) reported Operating Cash Flow of -$5.39 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-13
- MEDICINOVA, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$1.92M.
- MEDICINOVA, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$3.47M.
- MEDICINOVA, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$2.02M.
- MEDICINOVA, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$1.70M.
- MEDICINOVA, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$9.81M.
- MEDICINOVA, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$10.64M.
- MEDICINOVA, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$7.43M.
- MEDICINOVA, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$12.91M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 129 month | Net Cash Provided by (Used in) Operating Activities 132 month | Net Cash Provided by (Used in) Operating Activities 135 month | Net Cash Provided by (Used in) Operating Activities 138 month | Net Cash Provided by (Used in) Operating Activities 141 month | Net Cash Provided by (Used in) Operating Activities 144 month | Net Cash Provided by (Used in) Operating Activities 147 month | Net Cash Provided by (Used in) Operating Activities 150 month | Net Cash Provided by (Used in) Operating Activities 153 month | Net Cash Provided by (Used in) Operating Activities 156 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$5.39M 10-Q · filed 2026-08-13 | -$7.41M derived: sum of 3 quarters · filed 2026-08-13 | -$9.11M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||
| 2026-03-31 | -$3.47M 10-Q · filed 2026-05-14 | -$5.49M derived: sum of 2 quarters · filed 2026-05-14 | -$7.19M derived: sum of 3 quarters · filed 2026-05-14 | -$9.50M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||
| 2025-12-31 | -$2.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | -$3.72M derived: sum of 2 quarters · filed 2026-03-10 | -$6.03M derived: sum of 3 quarters · filed 2026-08-13 | -$9.81M 10-K · filed 2026-03-10 | ||||||||||
| 2025-09-30 | -$1.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$4.01M derived: sum of 2 quarters · filed 2026-08-13 | -$7.79M 10-Q · filed 2025-11-12 | -$9.72M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||
| 2025-06-30 | -$2.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$6.09M 10-Q · filed 2026-08-13 | -$8.02M derived: sum of 3 quarters · filed 2026-08-13 | -$10.05M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||
| 2025-03-31 | -$3.78M 10-Q · filed 2026-05-14 | -$5.72M derived: sum of 2 quarters · filed 2026-05-14 | -$7.75M derived: sum of 3 quarters · filed 2026-05-14 | -$10.56M derived: sum of 4 quarters · filed 2026-05-14 | ||||||||||
| 2024-12-31 | -$1.93M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | -$3.96M derived: sum of 2 quarters · filed 2026-03-10 | -$6.77M derived: sum of 3 quarters · filed 2026-03-10 | -$10.64M 10-K · filed 2026-03-10 | ||||||||||
| 2024-09-30 | -$2.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$4.84M derived: sum of 2 quarters · filed 2025-11-12 | -$8.71M 10-Q · filed 2025-11-12 | -$9.21M derived: sum of 4 quarters · filed 2025-11-12 | ||||||||||
| 2024-06-30 | -$2.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$6.68M 10-Q · filed 2025-08-14 | -$7.18M derived: sum of 3 quarters · filed 2025-08-14 | -$8.55M derived: sum of 4 quarters · filed 2025-08-14 | ||||||||||
| 2024-03-31 | -$3.87M 10-Q · filed 2025-05-13 | -$4.37M derived: sum of 2 quarters · filed 2025-05-13 | -$5.74M derived: sum of 3 quarters · filed 2025-05-13 | -$8.12M derived: sum of 4 quarters · filed 2025-05-13 | ||||||||||
| 2023-12-31 | -$499.06K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | -$1.87M derived: sum of 2 quarters · filed 2025-02-19 | -$4.25M derived: sum of 3 quarters · filed 2025-02-19 | -$7.43M 10-K · filed 2025-02-19 | ||||||||||
| 2023-09-30 | -$1.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$3.75M derived: sum of 2 quarters · filed 2024-11-13 | -$6.93M 10-Q · filed 2024-11-13 | -$10.94M derived: sum of 4 quarters · filed 2024-11-13 | ||||||||||
| 2023-06-30 | -$2.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$5.56M 10-Q · filed 2024-08-08 | -$9.57M derived: sum of 3 quarters · filed 2024-08-08 | -$12.29M derived: sum of 4 quarters · filed 2024-08-08 | ||||||||||
| 2023-03-31 | -$3.18M 10-Q · filed 2024-05-09 | -$7.18M derived: sum of 2 quarters · filed 2024-05-09 | -$9.90M derived: sum of 3 quarters · filed 2024-05-09 | -$12.36M derived: sum of 4 quarters · filed 2024-05-09 | ||||||||||
| 2022-12-31 | -$4.01M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | -$6.73M derived: sum of 2 quarters · filed 2024-02-15 | -$9.18M derived: sum of 3 quarters · filed 2024-02-15 | -$12.91M 10-K · filed 2024-02-15 | ||||||||||
| 2022-09-30 | -$2.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$5.18M derived: sum of 2 quarters · filed 2023-11-09 | -$8.90M 10-Q · filed 2023-11-09 | -$12.54M derived: sum of 4 quarters · filed 2023-11-09 | ||||||||||
| 2022-06-30 | -$2.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$6.18M 10-Q · filed 2023-08-09 | -$9.82M derived: sum of 3 quarters · filed 2023-08-09 | -$12.84M derived: sum of 4 quarters · filed 2023-08-09 | ||||||||||
| 2022-03-31 | -$3.73M 10-Q · filed 2023-05-11 | -$7.37M derived: sum of 2 quarters · filed 2023-05-11 | -$10.38M derived: sum of 3 quarters · filed 2023-05-11 | -$9.26M derived: sum of 4 quarters · filed 2023-05-11 | ||||||||||
| 2021-12-31 | -$3.64M derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-28 | -$6.65M derived: sum of 2 quarters · filed 2023-03-28 | -$5.53M derived: sum of 3 quarters · filed 2023-03-28 | -$9.38M 10-K/A · filed 2023-03-28 | ||||||||||
| 2021-09-30 | -$3.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$1.89M derived: sum of 2 quarters · filed 2022-11-10 | -$5.74M 10-Q · filed 2022-11-10 | -$7.69M derived: sum of 4 quarters · filed 2022-11-10 | ||||||||||
| 2021-06-30 | $1.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$2.73M 10-Q · filed 2022-08-11 | -$4.68M derived: sum of 3 quarters · filed 2022-08-11 | -$8.58M derived: sum of 4 quarters · filed 2022-08-11 | ||||||||||
| 2021-03-31 | -$3.85M 10-Q · filed 2022-05-12 | -$5.80M derived: sum of 2 quarters · filed 2022-05-12 | -$9.71M derived: sum of 3 quarters · filed 2022-05-12 | -$11.80M derived: sum of 4 quarters · filed 2022-05-12 | ||||||||||
| 2020-12-31 | -$1.95M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | -$5.86M derived: sum of 2 quarters · filed 2022-02-16 | -$7.95M derived: sum of 3 quarters · filed 2022-02-16 | -$10.83M 10-K · filed 2022-02-16 | ||||||||||
| 2020-09-30 | -$3.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$6.00M derived: sum of 2 quarters · filed 2021-11-12 | -$8.88M 10-Q · filed 2021-11-12 | -$11.28M derived: sum of 4 quarters · filed 2021-11-12 | ||||||||||
| 2020-06-30 | -$2.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$4.97M 10-Q · filed 2021-08-12 | -$7.37M derived: sum of 3 quarters · filed 2021-08-12 | -$9.41M derived: sum of 4 quarters · filed 2021-08-12 | ||||||||||
| 2020-03-31 | -$2.88M 10-Q · filed 2021-05-13 | -$5.28M derived: sum of 2 quarters · filed 2021-05-13 | -$7.32M derived: sum of 3 quarters · filed 2021-05-13 | -$8.97M derived: sum of 4 quarters · filed 2021-05-13 | ||||||||||
| 2019-12-31 | -$2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | -$4.44M derived: sum of 2 quarters · filed 2021-02-19 | -$6.10M derived: sum of 3 quarters · filed 2021-02-19 | -$9.12M 10-K · filed 2021-02-19 | ||||||||||
| 2019-09-30 | -$2.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-26 | -$3.69M derived: sum of 2 quarters · filed 2020-10-26 | -$6.72M 10-Q · filed 2020-10-26 | -$8.36M derived: sum of 4 quarters · filed 2020-10-26 | ||||||||||
| 2019-06-30 | -$1.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-28 | -$4.68M 10-Q · filed 2020-07-28 | -$6.33M derived: sum of 3 quarters · filed 2020-07-28 | -$8.06M derived: sum of 4 quarters · filed 2020-07-28 | ||||||||||
| 2019-03-31 | -$3.03M 10-Q · filed 2020-04-23 | -$4.67M derived: sum of 2 quarters · filed 2020-04-23 | -$6.41M derived: sum of 3 quarters · filed 2020-04-23 | -$8.06M derived: sum of 4 quarters · filed 2020-04-23 | ||||||||||
| 2018-12-31 | -$1.64M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | -$3.38M derived: sum of 2 quarters · filed 2020-02-13 | -$5.03M derived: sum of 3 quarters · filed 2020-02-13 | -$9.11M 10-K · filed 2020-02-13 | ||||||||||
| 2018-09-30 | -$1.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-24 | -$3.39M derived: sum of 2 quarters · filed 2019-10-24 | -$7.47M 10-Q · filed 2019-10-24 | -$8.52M derived: sum of 4 quarters · filed 2019-10-24 | ||||||||||
| 2018-06-30 | -$1.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-25 | -$5.73M 10-Q · filed 2019-07-25 | -$6.78M derived: sum of 3 quarters · filed 2019-07-25 | -$8.70M derived: sum of 4 quarters · filed 2019-07-25 | ||||||||||
| 2018-03-31 | -$4.08M 10-Q · filed 2019-04-25 | -$5.13M derived: sum of 2 quarters · filed 2019-04-25 | -$7.05M derived: sum of 3 quarters · filed 2019-04-25 | |||||||||||
| 2017-12-31 | -$1.05M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | -$2.97M derived: sum of 2 quarters · filed 2019-02-13 | -$6.92M 10-K · filed 2019-02-13 | |||||||||||
| 2017-09-30 | -$1.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-25 | -$5.88M 10-Q · filed 2018-10-25 | ||||||||||||
| 2017-06-30 | -$3.96M 10-Q · filed 2018-07-23 | |||||||||||||
| 2016-12-31 | -$6.55M 10-K · filed 2019-02-13 | |||||||||||||
| 2013-12-31 | -$4.02M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | -$5.93M derived: sum of 2 quarters · filed 2014-03-27 | -$8.02M derived: sum of 3 quarters · filed 2014-03-27 | -$10.65M 10-K · filed 2014-03-27 | ||||||||||
| 2013-09-30 | -$1.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | -$4.00M derived: sum of 2 quarters · filed 2013-11-07 | -$6.62M 10-Q · filed 2013-11-07 | -$8.81M derived: sum of 4 quarters · filed 2014-03-27 | -$216.34M 10-Q · filed 2013-11-07 | |||||||||
| 2013-06-30 | -$2.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | -$4.72M 10-Q · filed 2013-08-08 | -$6.91M derived: sum of 3 quarters · filed 2014-03-27 | -$9.31M derived: sum of 4 quarters · filed 2014-03-27 | -$214.43M 10-Q · filed 2013-08-08 | |||||||||
| 2013-03-31 | -$2.62M 10-Q · filed 2013-05-08 | -$4.81M derived: sum of 2 quarters · filed 2014-03-27 | -$7.22M derived: sum of 3 quarters · filed 2014-03-27 | -$11.06M derived: sum of 4 quarters · filed 2014-03-27 | -$212.33M 10-Q · filed 2013-05-08 | |||||||||
| 2012-12-31 | -$2.19M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | -$4.59M derived: sum of 2 quarters · filed 2014-03-27 | -$8.44M derived: sum of 3 quarters · filed 2014-03-27 | -$11.86M 10-K · filed 2014-03-27 | -$209.71M 10-K · filed 2013-03-28 | |||||||||
| 2012-09-30 | -$2.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | -$6.25M derived: sum of 2 quarters · filed 2013-11-07 | -$9.68M 10-Q · filed 2013-11-07 | -$10.62M derived: sum of 4 quarters · filed 2013-11-07 | -$207.53M 10-Q · filed 2012-11-08 | |||||||||
| 2012-06-30 | -$3.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | -$7.27M 10-Q · filed 2013-08-08 | -$8.22M derived: sum of 3 quarters · filed 2013-08-08 | -$11.20M derived: sum of 4 quarters · filed 2013-08-08 | -$205.12M 10-Q · filed 2012-08-09 | |||||||||
| 2012-03-31 | -$3.43M 10-Q · filed 2013-05-08 | -$4.37M derived: sum of 2 quarters · filed 2013-05-08 | -$7.35M derived: sum of 3 quarters · filed 2013-05-08 | -$12.77M derived: sum of 4 quarters · filed 2013-05-08 | -$201.28M 10-Q · filed 2012-05-10 | |||||||||
| 2011-12-31 | -$944.35K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | -$3.92M derived: sum of 2 quarters · filed 2013-03-28 | -$9.35M derived: sum of 3 quarters · filed 2013-03-28 | -$13.31M 10-K · filed 2013-03-28 | -$197.85M 10-K · filed 2012-03-29 | |||||||||
| 2011-09-30 | -$2.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | -$8.40M derived: sum of 2 quarters · filed 2012-11-08 | -$12.36M 10-Q · filed 2012-11-08 | -$15.98M derived: sum of 4 quarters · filed 2012-11-08 | -$196.90M 10-Q · filed 2011-11-14 | |||||||||
| 2011-06-30 | -$5.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | -$9.38M 10-Q · filed 2012-08-09 | -$13.00M derived: sum of 3 quarters · filed 2012-08-09 | -$16.82M derived: sum of 4 quarters · filed 2012-08-09 | -$193.29M 10-Q · filed 2011-08-15 | |||||||||
| 2011-03-31 | -$3.96M 10-Q · filed 2012-05-10 | -$7.58M derived: sum of 2 quarters · filed 2012-05-10 | -$11.40M derived: sum of 3 quarters · filed 2012-05-10 | |||||||||||
| 2010-12-31 | -$3.62M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-29 | -$7.44M derived: sum of 2 quarters · filed 2012-03-29 | -$17.70M 10-K · filed 2012-03-29 | |||||||||||
| 2010-09-30 | -$3.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | -$14.08M 10-Q · filed 2011-11-14 | ||||||||||||
| 2010-06-30 | -$10.26M 10-Q · filed 2011-08-15 | |||||||||||||
| 2009-12-31 | -$17.01M 10-K · filed 2012-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |